A healthy commitment to your health.

A healthy commitment to your health.

We believe a dedication to health and wellbeing applies to all living things.

Human Health

The first research effort of LLOYD, Inc.’s expansion into human pharmaceuticals culminated when LLOYD received U.S. Food and Drug Administration (FDA) approval in 2002 for the New Drug Application for Thyro-Tabs®, levothyroxine sodium tablets, USP.

LLOYD, Inc. has entered into a business relationship with Forest Laboratories, Inc. to market the human Thyro-Tabs products under Forest Pharmaceuticals, Inc.'s brand name Levothroid®, levothyroxine sodium tablets, USP.

LLOYD is continuing to develop additional products designed to improve the health and wellbeing of people worldwide.